BBVA to Present Q3 2026 Results on October 29
Banco Bilbao Vizcaya Argentaria, S.A. will present its Q3 2026 results on October 29, emphasizing transparency in the commercial banking sector.
Alpha Tau Medical Expands REGAIN Trial After FDA Approval
Alpha Tau Medical Ltd. receives FDA approval to expand its REGAIN trial for recurrent glioblastoma, enhancing treatment options and research data.
GSK's Jemperli Approved for Advanced Rectal Cancer Treatment
GSK plc's Jemperli receives FDA approval as the first immunotherapy for advanced rectal cancer, offering new hope for patients.
argenx SE reveals Phase 3 results for autoimmune myositis drug
argenx SE announces Phase 3 results for efgartigimod in autoimmune myositis, showcasing significant patient improvements. Presentation at ACR Convergence 2026 set.
Brainsway Ltd. Partners with Inland Psychiatry Medical Group
Brainsway Ltd. announces a strategic collaboration with Inland Psychiatry Medical Group to enhance interventional psychiatry treatments.
Golar LNG sets date for Q3 2026 results release
Golar LNG Ltd announces Q3 2026 results date for November 18, 2026, with a webcast presentation to follow, highlighting its operations in water transportation.
GSK reports positive data for Ris-Rez in lung cancer trial
GSK plc announces positive trial results for Ris-Rez, a new treatment for extensive-stage small cell lung cancer, showcasing its commitment to oncology advancements.
Americas Gold & Silver Corp Announces Record Silver Production
Americas Gold & Silver Corp reports record silver production of 800,458 ounces for Q3 2026, reflecting strong operational performance and growth.
Blue Moon Metals closes C$35 million private placement
Blue Moon Metals Inc. secures C$35 million in private placement to advance the Springer Project and appoints new board member.
Gix Internet Ltd. adopts corporate governance exemption
Gix Internet Ltd. adopts a corporate governance exemption, easing regulatory burdens and aligning with Nasdaq rules, impacting the prepackaged software sector.
Elbit Systems Wins $235 Million Defense Contract
Elbit Systems Ltd secures a $235 million contract to supply rocket systems to a European customer, highlighting strong demand in the defense sector.
Evaxion reports three-year follow-up data for cancer vaccine
Evaxion A/S shares promising three-year results from its phase 2 trial of personalized cancer vaccine EVX-01, indicating sustained patient responses.
Alterity Therapeutics to Present at Craig-Hallum Conference
Alterity Therapeutics will showcase its neurodegenerative disease treatments at the Craig-Hallum Biotech Catalyst Conference on October 22, 2026.
Zhihu Inc. Grants 809,802 Restricted Share Units to Employees
Zhihu Inc. grants 809,802 RSUs to employees under its 2022 Share Incentive Plan, aiming to enhance retention and align interests with shareholders.
XPENG INC. Grants 4.6 Million Restricted Share Units
XPENG INC. grants 4.6 million restricted share units to employees, enhancing retention and aligning interests with shareholders amid competitive EV market.
JE Cleantech Holdings Holds Annual General Meeting, Elects Directors
JE Cleantech Holdings Ltd held its Annual General Meeting on October 16, 2026, electing new directors and ratifying an accounting firm.
Nuran Wireless CEO to Meet Telecom Leaders Amid Expansion Plans
Nuran Wireless CEO Francis Létourneau will meet with telecom leaders in Africa as the company targets significant expansion in its tower rollout.
SEALSQ Corp incorporates previous filings into registration
SEALSQ Corp has filed a report with the SEC to incorporate previous filings into its registration statements, impacting the semiconductor industry.
Westport Fuel Systems Inc. Rebrands as Aetherion Technologies
Westport Fuel Systems Inc. has officially changed its name to Aetherion Technologies Inc., with shares to trade under the new name starting October 23, 2026.
Neo-Concept International Group Plans Share Consolidation
Neo-Concept International Group Holdings Ltd announces plans for a share consolidation at an extraordinary general meeting on October 29, 2026.